Neurogene Inc. (NGNE)
Neurogene Announces First Participant Dosed in Embolden™ Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome
Evaxion Biotech A/S (EVAX)
Evaxion announces business update and third quarter 2025 financial results
Cybin Inc (CYBN)
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
Catalyst Biosciences Inc. (CBIO)
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Plus Therapeutics Inc (PSTV)
Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0
Silence Therapeutics, Plc. (SLNCF)
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Cognition Therapeutics Inc. (CGTX)
Cognition Therapeutics Reports Financial Results for the Third Quarter 2025 and Highlights Progress Across Clinical Programs
Organon & Co. (OGN)
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
Lexicon Pharmaceuticals Inc. (LXRX)
Lexicon Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides R&D Updates
Collegium Pharmaceutical Inc (COLL)
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance